A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
about
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraSequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.
P2860
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A prospective study of an alem ...... advanced lymphoid malignancies
@ast
A prospective study of an alem ...... advanced lymphoid malignancies
@en
type
label
A prospective study of an alem ...... advanced lymphoid malignancies
@ast
A prospective study of an alem ...... advanced lymphoid malignancies
@en
prefLabel
A prospective study of an alem ...... advanced lymphoid malignancies
@ast
A prospective study of an alem ...... advanced lymphoid malignancies
@en
P2093
P2860
P1433
P1476
A prospective study of an alem ...... advanced lymphoid malignancies
@en
P2093
Ann A Jakubowski
Craig S Sauter
Esperanza B Papadopoulos
Hugo Castro-Malaspina
James W Young
Joanne F Chou
Michael Scordo
Miguel-Angel Perales
P2860
P304
P356
10.3109/10428194.2014.894185
P577
2014-03-20T00:00:00Z